SRS Capital Advisors »

Kempharm shares owned by SRS Capital Advisors

Quarter-by-quarter ownership of Kempharm (ZVRA) shares owned by SRS Capital Advisors from 13F filings

Historical chart of SRS Capital Advisors investment in Kempharm

Tip: Access up to 7 years of quarterly data

All positions including Kempharm held by SRS Capital Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kempharm by SRS Capital Advisors

Quarter filed Position value Share count Share price at filing
2025-12-31 $779 87 8.97
2024-12-31 $725 87 8.34
2024-09-30 $603 87 6.94
2024-06-30 $426 87 4.91

More positions owned by SRS Capital Advisors

Vanguard Index Fds Growth Etf (VUG)
Vanguard Index Fds Value Etf (VTV)
Apple (AAPL)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Vanguard Index Fds Total Stk Mkt (VTI)
NVIDIA Corporation (NVDA)
Eldridge Bbb-b Clo Etf Etf (CLOZ)
Vanguard Index Fds Mid Cap Etf (VO)
American Centy Etf Tr Us Large Cap Vlu (AVLV)
Ishares Tr Ishs 1-5yr Invs (IGSB)
First Tr Exchange Traded Risng Divd Achiv (RDVY)
Schwab Strategic Tr Us Tips Etf (SCHP)
Ishares Tr Core Us Aggbd Et (AGG)
Microsoft Corporation (MSFT)

View all positions for SRS Capital Advisors

Top funds holding Kempharm

BlackRock
Woodline Partners
Vanguard Group
Caption Management
Adage Capital Partners GP
Nantahala Capital Management
FMR
State Street Corporation
Geode Capital Management
Legal & General Group
Millennium Management
683 Capital Management
Royce & Associates
D. E. Shaw & Co
Marshall Wace

View all funds holding Kempharm